Literature DB >> 33677421

The role of tumor necrosis factor in triggering activation of natural killer cell, multi-organ mitochondrial dysfunction and hypertension during pregnancy.

Aswathi Jayaram1, Evangeline Deer1, Lorena M Amaral1, Nathan Campbell1, Venkata Ramana Vaka1, Mark Cunningham1, Tarek Ibrahim1, Denise C Cornelius1, Babbette B LaMarca2.   

Abstract

Pre-eclampsia (PE) is a hypertensive disorder of pregnancy associated with chronic inflammation, mitochondrial (mt) dysfunction and fetal demise. Natural Killer cells (NK cells) are critical for the innate immune response against tumors or infection by disrupting cellular mt function and causing cell death. Although NK cells can be stimulated by Tumor necrosis factor alpha (TNF-α), we don't know the role of TNF-α on NK cell mediated mt dysfunction during PE. Our objective was to determine if mechanisms of TNF-α induced hypertension included activation of NK cells and multi-organ mt dysfunction during pregnancy. Pregnant rats were divided into 2 groups: normal pregnant (NP) (n = 18) and NP + TNF-α (n = 18). On gestational day 14, TNF-α (50 ng/ml) was infused via mini-osmotic pump and on day 18, carotid artery catheters were inserted. Blood pressure (MAP) and samples were collected on day 19. TNF-α increased MAP (109 ± 2 vs 100 ± 2, p < 0.05), circulating cytolytic NK cells (0.771 ± 0.328 vs.0.008 ± 0.003% gated, <0.05) and fetal reabsorptions compared to NP rats. Moreover, TNF-α caused mtROS in the placenta (12976 ± 7038 vs 176.9 ± 68.04% fold, p < 0.05) and in the kidney (2191 ± 1027 vs 816 ± 454.7% fold, p < 0.05) compared to NP rats. TNF-α induced hypertension is associated fetal demise, activation of NK cells and multi-organ mt dysfunction which could be mechanisms for fetal demise and hypertension. Understanding of the mechanisms by which TNF-α causes pathology is important for the use of anti-TNF-α therapeutic agents in pregnancies complicated by PE.
Copyright © 2021 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytokines; Fetal demise; Hypertension; Inflammation; Oxidative stress; Pregnancy

Mesh:

Substances:

Year:  2021        PMID: 33677421      PMCID: PMC8681863          DOI: 10.1016/j.preghy.2021.02.006

Source DB:  PubMed          Journal:  Pregnancy Hypertens        ISSN: 2210-7789            Impact factor:   2.494


  44 in total

1.  Vitamins C and E and the risks of preeclampsia and perinatal complications.

Authors:  Alice R Rumbold; Caroline A Crowther; Ross R Haslam; Gustaaf A Dekker; Jeffrey S Robinson
Journal:  N Engl J Med       Date:  2006-04-27       Impact factor: 91.245

2.  Tumor necrosis factor receptor deficiency exacerbated Adriamycin-induced cardiomyocytes apoptosis: an insight into the Fas connection.

Authors:  Yu-Chin Lien; Shu-Mei Lin; Ramaneeya Nithipongvanitch; Terry D Oberley; Teresa Noel; Qing Zhao; Chotiros Daosukho; Daret K St Clair
Journal:  Mol Cancer Ther       Date:  2006-02       Impact factor: 6.261

3.  Expression of inflammatory cytokines in placentas from women with preeclampsia.

Authors:  D F Benyo; A Smarason; C W Redman; C Sims; K P Conrad
Journal:  J Clin Endocrinol Metab       Date:  2001-06       Impact factor: 5.958

4.  Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats.

Authors:  Babbette LaMarca; Gerd Wallukat; Mayte Llinas; Florian Herse; Ralf Dechend; Joey P Granger
Journal:  Hypertension       Date:  2008-10-13       Impact factor: 10.190

Review 5.  Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities.

Authors:  Shane R Thomas; Paul K Witting; Grant R Drummond
Journal:  Antioxid Redox Signal       Date:  2008-10       Impact factor: 8.401

6.  Ghrelin prevents doxorubicin-induced cardiotoxicity through TNF-alpha/NF-kappaB pathways and mitochondrial protective mechanisms.

Authors:  Zhiwei Xu; Shiqing Lin; Weikang Wu; Hongmei Tan; Zhi Wang; Chao Cheng; Lihe Lu; Xuanhong Zhang
Journal:  Toxicology       Date:  2008-03-06       Impact factor: 4.221

Review 7.  Pathophysiology of hypertension in response to placental ischemia during pregnancy: a central role for endothelin?

Authors:  Babbette D LaMarca; Barbara T Alexander; Jeffery S Gilbert; Michael J Ryan; Mona Sedeek; Sydney R Murphy; Joey P Granger
Journal:  Gend Med       Date:  2008

Review 8.  Role of renal oxygenation and mitochondrial function in the pathophysiology of acute kidney injury.

Authors:  Noureddin Nourbakhsh; Prabhleen Singh
Journal:  Nephron Clin Pract       Date:  2014-09-24

Review 9.  Natural Killer Cells: Development, Maturation, and Clinical Utilization.

Authors:  Alex M Abel; Chao Yang; Monica S Thakar; Subramaniam Malarkannan
Journal:  Front Immunol       Date:  2018-08-13       Impact factor: 7.561

10.  Mitochondria-dependent and -independent regulation of Granzyme B-induced apoptosis.

Authors:  G MacDonald; L Shi; C Vande Velde; J Lieberman; A H Greenberg
Journal:  J Exp Med       Date:  1999-01-04       Impact factor: 14.307

View more
  4 in total

1.  Correlation of Blood Lipid and Serum Inflammatory Factor Levels With Hypertensive Disorder Complicating Pregnancy.

Authors:  Wangxiang Chen; Yan Guo; Xia Yao; Di Zhao
Journal:  Front Surg       Date:  2022-06-17

2.  Progesterone Induced Blocking Factor Reduces Hypertension and Placental Mitochondrial Dysfunction in Response to sFlt-1 during Pregnancy.

Authors:  Evangeline Deer; Jalisa Jones; Denise C Cornelius; Kyleigh Comley; Owen Herrock; Nathan Campbell; Sarah Fitzgerald; Tarek Ibrahim; Babbette LaMarca; Lorena M Amaral
Journal:  Cells       Date:  2021-10-20       Impact factor: 7.666

Review 3.  Natural Killer Cells in Hepatic Ischemia-Reperfusion Injury.

Authors:  Miao Huang; Hao Cai; Bing Han; Yuhan Xia; Xiaoni Kong; Jinyang Gu
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

Review 4.  Is Mitochondrial Oxidative Stress a Viable Therapeutic Target in Preeclampsia?

Authors:  Ramana Vaka; Evangeline Deer; Babbette LaMarca
Journal:  Antioxidants (Basel)       Date:  2022-01-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.